"If we accept the premise that NEU management aren't stupid, then it's interesting to speculate why they'd mention the lower mortality rate in the first place. Presumably because it puts a positive spin on things. "
My take is they mention it because the study is likely to be underpowered for mortality and so a non statistically significant result doesnt actually tell us much with regard to mortality. they then go on to talk about how important the bio markers are...and I agree.
Bottom line the result for mortality can be not significantly different (but clearly underpowered) with convincing bio markers and the drug is still a candidate.
Don't get me wrong I think this company is great and nothing Ive said should imply stupidity on the part of NEU.
Noticed recevied @ 1.15pm., page-48
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.72 |
Change
-0.150(0.72%) |
Mkt cap ! $2.648B | |||
| Open | High | Low | Value | Volume |
| $20.96 | $21.28 | $20.61 | $4.984M | 239.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 782 | $20.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.72 | 1021 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |